M. Lebwohl, “Once-Daily Roflumilast Cream 0.3%, a Potent Phosphodiesterase-4 Inhibitor, Provided Safe and Effective Treatment of Psoriasis in the DERMIS-1 and DERMIS-2 Phase 3 Trials”, J of Skin, vol. 5, no. 6, p. s42, Nov. 2021.